A series of seton techniques involving "top-down therapy" for patients with Crohn's disease who initially presented with perianal fistulas
- PMID: 31559354
 - PMCID: PMC6752135
 - DOI: 10.23922/jarc.2017-044
 
A series of seton techniques involving "top-down therapy" for patients with Crohn's disease who initially presented with perianal fistulas
Abstract
Objectives: We determined the outcomes of seton treatment through a series of techniques using biological agents (BIOs) in 18 patients with Crohn's disease (CD) who initially presented with perianal fistulas.
Methods: The patients underwent seton drainage using three seton types: a Penrose tube for fistulas with massive purulent discharge, a vessel loop for a small amount of discharge, and a rubber band for unproductive fistulas. If the distal end of the fistula extended more than 4 cm from the anal orifice, the skin and subcutaneous tissue were dissected along the outer edge of the anal sphincter to divide the fistulous tract into two portions. One seton encircled the sphincter from the primary opening throughout the anal canal (medial seton), and the other was inserted through the distal tract outside the sphincter (lateral seton). A BIO was then introduced immediately. When discharge ceased, the Penrose tube or vessel loop was replaced sequentially with a rubber band, which was tied fittingly and subsequently removed in medial to lateral order.
Results: The mean interval between fistula onset and CD diagnosis was 2.1 years, and that between CD diagnosis and introduction of BIOs was 0.5 years. The mean follow-up duration was 4 years. The BIOs currently used were infliximab in 10 patients, adalimumab in 7, and ustekinumab in 1. The overall success rate was 94.4%, including unproductive fistulas in 10 (55.6%) patients and fistula disappearance in 7 (38.9%).
Conclusions: Our seton drainage techniques via the "top-down" approach represent a promising avenue for treating perianal fistulas in patients with CD.
Keywords: Crohn's disease; biological agents; perianal fistula; seton.
Conflict of interest statement
Conflicts of Interest There are no conflicts of interest.
Figures
              
              
              
              
                
                
                
              
              
              
              
                
                
                References
- 
    
- Keighley MR, Allan RN. Current status and influence of operation on perianal Crohn's disease. Int J Colorectal Dis. 1986 Jan; 1(2): 104-7. - PubMed
 
 - 
    
- van Koperen PJ, Safiruddin F, Bemelman WA, et al. Outcome of surgical treatment for fistula in ano in Crohn's disease. Br J Surg. 2009 June; 96(6): 675-9. - PubMed
 
 - 
    
- Halme L, Sainio AP. Factors related to frequency, type, and outcome of anal fistulas in Crohn's disease. Dis Colon Rectum. 1995 Jan; 38(1): 55-9. - PubMed
 
 - 
    
- Vogel JD, Johnson EK, Morris AM, et al. Clinical Practice Guideline for the Management of Anorectal Abscess, Fistula-in-Ano, and Rectovaginal Fistula. Dis Colon Rectum. 2016 Dec; 59(12): 1117-33. - PubMed
 
 
LinkOut - more resources
Full Text Sources